The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116168263 11616826 3 F 2005 20160721 20151009 20160802 PER US-BAYER-2015-434883 BAYER 0.00 A F Y 152.38000 KG 20160802 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116168263 11616826 1 PS AVELOX MOXIFLOXACIN HYDROCHLORIDE 1 400 MG, UNK 21085 400 MG FILM-COATED TABLET
116168263 11616826 2 SS AVELOX MOXIFLOXACIN HYDROCHLORIDE 1 UNK 21085 FILM-COATED TABLET
116168263 11616826 3 SS AVELOX MOXIFLOXACIN HYDROCHLORIDE 1 400 MG, UNK 21085 400 MG FILM-COATED TABLET
116168263 11616826 4 C ROXICODONE OXYCODONE HYDROCHLORIDE 1 30 MG, QID 0 30 MG QID
116168263 11616826 5 C ROXICODONE OXYCODONE HYDROCHLORIDE 1 0
116168263 11616826 6 C ROXICODONE OXYCODONE HYDROCHLORIDE 1 0
116168263 11616826 7 C ROXICODONE OXYCODONE HYDROCHLORIDE 1 0
116168263 11616826 8 C XANAX ALPRAZOLAM 1 UNK 0
116168263 11616826 9 C COUMADIN WARFARIN SODIUM 1 UNK 0
116168263 11616826 10 C COUMADIN WARFARIN SODIUM 1 0
116168263 11616826 11 C LEVAQUIN LEVOFLOXACIN 1 UNK 0
116168263 11616826 12 C LEVAQUIN LEVOFLOXACIN 1 500 MG, UNK 0 500 MG
116168263 11616826 13 C LEVOTHYROXINE. LEVOTHYROXINE 1 175 ?G, QD 0 175 UG QD
116168263 11616826 14 C LEVOTHYROXINE. LEVOTHYROXINE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116168263 11616826 1 Sinusitis
116168263 11616826 2 Sinusitis
116168263 11616826 3 Sinusitis
116168263 11616826 4 Rheumatoid arthritis
116168263 11616826 5 Pain
116168263 11616826 6 Nerve injury
116168263 11616826 7 Osteoporosis
116168263 11616826 8 Depression
116168263 11616826 9 Depression
116168263 11616826 10 Anxiety
116168263 11616826 11 Infection
116168263 11616826 12 Infection
116168263 11616826 13 Hypothyroidism
116168263 11616826 14 Thyroid disorder

Outcome of event

Event ID CASEID OUTC COD
116168263 11616826 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
116168263 11616826 Anxiety
116168263 11616826 Cardiovascular disorder
116168263 11616826 Mental disorder
116168263 11616826 Musculoskeletal injury
116168263 11616826 Nervous system disorder
116168263 11616826 Neuropathy peripheral
116168263 11616826 Skin injury
116168263 11616826 Stress

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116168263 11616826 1 20020323 0
116168263 11616826 2 200503 0
116168263 11616826 3 20050518 0
116168263 11616826 4 2005 0
116168263 11616826 8 2005 2008 0
116168263 11616826 9 2002 2003 0
116168263 11616826 11 20020710 0
116168263 11616826 12 20020724 0
116168263 11616826 13 2001 0